Two latent and two hyperstable polymeric forms of human neuroserpin

Biophysical Journal

Volumn 99, Issue 10, 2010, Pages 3402-3411

  Ricagno, Stefano ^a,c,d   Pezzullo, Margherita ^a   Barbiroli, Alberto ^b   Manno, Mauro ^e   Levantino, Matteo ^f   Santangelo, Maria Grazia ^f   Bonomi, Francesco ^b   Bolognesi, Martino ^a  

^a CIMaINa (Centro Interdisciplinare Materiali e Interfacce Nanostrutturati)   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d Istituto di Ricovero e Cura a Carattere Scientifico di Diritto Pubblico   (Italy)

^e CNR   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649290751     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.09.021     Document Type: Article

References (40)

1. Miranda, E., and D. A. Lomas. 2006. Neuroserpin: a serpin to think about. Cell. Mol. Life Sci. 63:709-722.
2. Whisstock, J. C., and S. P. Bottomley. 2006. Molecular gymnastics: serpin structure, folding and misfolding. Curr. Opin. Struct. Biol. 16:761-768.
3. Hastings, G. A., T. A. Coleman, ., D. A. Lawrence. 1997. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J. Biol. Chem. 272:33062-33067.
4. Yepes, M., and D. A. Lawrence. 2004. Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system? Trends Cardiovasc. Med. 14:173-180. (Pubitemid 38942824)
5. Coutelier, M., S. Andries, ., C. Godfraind. 2008. Neuroserpin mutation causes electrical status epilepticus of slow-wave sleep. Neurology. 71:64-66.
6. Gooptu, B., and D. A. Lomas. 2009. Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu. Rev. Biochem. 78:147-176.
7. Belorgey, D., D. C. Crowther,., D. A. Lomas. 2002. Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. J. Biol. Chem. 277:17367-17373.
8. Belorgey, D., L. K. Sharp, ., D. A. Lomas. 2004. Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB. Eur. J. Biochem. 271:3360-3367.
9. Onda, M., D. Belorgey, ., D. A. Lomas. 2005. Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies. J. Biol. Chem. 280:13735-13741.
10. Carrell, R. W., and D. A. Lomas. 2002. α1-Antitrypsin deficiency- a model for conformational diseases. N. Engl. J. Med. 346:45-53.
11. Huntington, J. A., R. J. Read, and R. W. Carrell. 2000. Structure of a serpin-protease complex shows inhibition by deformation. Nature. 407:923-926.
12. Barker-Carlson, K., D. A. Lawrence, and B. S. Schwartz. 2002. Acyl-enzyme complexes between tissue-type plasminogen activator and neuroserpin are short-lived in vitro. J. Biol.Chem. 277:46852-46857.
13. Ricagno, S., S. Caccia, ., M. Bolognesi. 2009. Human neuroserpin: structure and time-dependent inhibition. J. Mol. Biol. 388:109-121.
14. Kaslik, G., J. Kardos,., L. Gráf. 1997. Effects of serpin binding on the target proteinase: global stabilization, localized increased structural flexibility, and conserved hydrogen bonding at the active site. Biochemistry. 36:5455-5464.
15. Mottonen, J., A. Strand, ., E. J. Goldsmith. 1992. Structural basis of latency in plasminogen activator inhibitor-1. Nature. 355:270-273.
16. Zhang, Q., A. M. Buckle,., J. C. Whisstock. 2007. The N terminus of the serpin, tengpin, functions to trap the metastable native state. EMBO Rep. 8:658-663.
17. Zhang, Q., R. H. Law, ., A. M. Buckle. 2008. A structural basis for loop C-sheet polymerization in serpins. J. Mol. Biol. 376:1348-1359.
18. Gooptu, B., B. Hazes,., D. A. Lomas. 2000. Inactive conformation of the serpin a(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc. Natl. Acad. Sci. USA. 97:67-72.
19. Marszal, E., and A. Shrake. 2006. Serpin crystal structure and serpin polymer structure. Arch. Biochem. Biophys. 453:123-129.
20. Lomas, D. A., D. L. Evans,., R.W. Carrell. 1992. The mechanism of Z α1-antitrypsin accumulation in the liver. Nature. 357:605-607.
21. Yamasaki, M., W. Li, ., J. A. Huntington. 2008. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature. 455:1255-1258.
22. James, E. L., J. C. Whisstock, ., S. P. Bottomley. 1999. Probing the unfolding pathway of a1-antitrypsin. J. Biol. Chem. 274:9482-9488.
23. Shortle, D., and M. S. Ackerman. 2001. Persistence of native-like topology in a denatured protein in 8 M urea. Science. 293:487-489.
24. Davis, R. L., A. E. Shrimpton, ., D. A. Lomas. 1999. Familial dementia caused by polymerization of mutant neuroserpin. Nature. 401:376-379.
25. Barth, A. 2007. Infrared spectroscopy of proteins. Biochim. Biophys. Acta. 1767:1073-1101.
26. Krimm, S., and J. Bandekar. 1986. Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv. Protein Chem. 38:181-364.
27. Kubelka, J., and T. A. Keiderling. 2001. Differentiation of β-sheetforming structures: ab initio-based simulations of IR absorption and vibrational CD for model peptide and protein β-sheets. J. Am. Chem. Soc. 123:12048-12058.
28. Zandomeneghi, G., M. R. Krebs, ., M. Fändrich. 2004. FTIR reveals structural differences between native β-sheet proteins and amyloid fibrils. Protein Sci. 13:3314-3321.
29. Dzwolak,W., R. Ravindra,., R.Winter. 2003. Aggregation of bovine insulin probed by DSC/PPC calorimetry and FTIR spectroscopy. Biochemistry. 42:11347-11355.
30. Frare, E., M. F. Mossuto, ., A. Fontana. 2009. Characterization of oligomeric species on the aggregation pathway of human lysozyme. J. Mol. Biol. 387:17-27.
31. Frare, E., M. F. Mossuto, ., A. Fontana. 2006. Identification of the core structure of lysozyme amyloid fibrils by proteolysis. J. Mol. Biol. 361:551-561.
32. Chiou, A., P. Hägglöf, ., D. Klenerman. 2009. Probing neuroserpin polymerization and interaction with amyloid-b peptides using single molecule fluorescence. Biophys. J. 97:2306-2315.
33. Lomas, D. A., P. R. Elliott, ., R. W. Carrell. 1995. α1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J. Biol. Chem. 270:16864-16870.
34. Takehara, S., M. Onda,., D. A. Lomas. 2009. The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability. J. Mol. Biol. 388:11-20.
35. McGowan, S., A. M. Buckle, ., J. C. Whisstock. 2006. X-ray crystal structure of MENT: evidence for functional loop-sheet polymers in chromatin condensation. EMBO J. 25:3144-3155.
36. Nar, H., M. Bauer,., P. J. Declerck. 2000. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation. J. Mol. Biol. 297:683-695.
37. Sharp, A. M., P. E. Stein,., R. J. Read. 1999. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure. 7:111-118.
38. Carrell, R. W., P. E. Stein, ., M. R. Wardell. 1994. Biological implications of a 3 A structure of dimeric antithrombin. Structure. 2:257-270.
39. Belorgey, D., P. Hagglof, M. Onda, and D. A. Lomas. 2009. pH-Dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of β-sheet A and polymerization. Protein Sci. 19:220-228.
40. Janciauskiene, S., S. Eriksson, ., D. A. Lomas. 2004. Differential detection of PAS-positive inclusions formed by the Z, Siiyama, and Mmalton variants of a1-antitrypsin. Hepatology. 40:1203-1210.